To promote the Cancer Research Institute’s global awareness campaign, Cancer Immunotherapy Month, ACEA Biosciences will be participating in the #WearWhite campaign on June 15 and providing an Immunotherapy Research Grant to help scientists in the field of cancer research achieve their goals. As a leading innovator in the development of tools for the cancer research […]

Under this agreement, MaxCyte’s second signed with a U.S. NIH institute in the past year, the Company and the National Heart, Lung, and Blood Institute will explore development of new therapies for sickle cell disease using MaxCyte’s gene-correction platform   Gaithersburg, Maryland – MaxCyte, Inc. today announces it has entered into a Cooperative Research and Development Agreement (“CRADA”) […]

NGS-based microbiome profiling delivers enhanced insights for metagenomics studies Gut bacteria play an important role in human health, as changes in the microbiome can be potentially harmful, and may be associated with chronic conditions such as inflammatory bowel disease, obesity and cancer.* Next-generation sequencing (NGS) technologies can deliver the necessary details to characterize microbial communities, […]

Joint offering enables acceleration of genomic panel design for translational and clinical disease research SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation announced today that it has entered into a co-marketing agreement with Genomenon to offer evidence-based genomic panel design services for translational and clinical disease research. The rapidly expanding knowledge base of genes and variants associated with […]

Zymo Research and CosmosID announce their partnership to provide microbiome researchers with an integrated end to end solution for accurate microbiome analysis.   The partnership combines Zymo Research’s complete microbiomics product portfolio from sample collection/preservation, mock microbial community standards, nucleic acid isolation, and library preparation with the largest curated microbiome database maintained and powered by CosmosID. The combined technologies of […]

Torrance, Calif. – Phenomenex, Inc., a global leader in the research and manufacturer of advanced technologies for the separation sciences, announced today that it has opened an office to directly serve customers in Singapore. Phenomenex has been doing business in Singapore through distributors since 1993. Direct presence allows Phenomenex to provide customers with a variety […]

Mannheim, German Park Systems world-leading manufacturer of Atomic Force Microscopes (AFM), announces the appointment of CN Technical Services Ltd as the sales representative of Park Systems in the United Kingdom and Ireland. CN Tech’s excellent customer service and 10-year experience in delivering excellent technological solutions in UK microscopy market has earned them to UK representatives […]

Gonorrhoea, Deadly Plague and Dysentery Among Collection of Bacterial Genomes Now Publicly Available Through Collaboration with Pacific Biosciences HINXTON, United Kingdom and MENLO PARK, Calif. — The genomes of more than 3,000 bacteria, including some of the world’s most dangerous, have been sequenced by researchers at the Wellcome Sanger Institute in collaboration with Pacific Biosciences (PacBio). Infecting tens of millions of […]

FUJIFILM Cellular Dynamics, Inc., licenses University of California – Irvine’s technologies for derivation of microglia MADISON, Wis. — FUJIFILM Cellular Dynamics, Inc. (FCDI), a leading developer and manufacturer of human induced pluripotent stem cells (iPSCs) and differentiated tissue-specific iPSCs, announced today that it has entered into an exclusive patent license agreement with the University of California – Irvine (UCI) through its […]

BEVERLY, Mass. — LexaGene Holdings Inc. (OTCQB:LXXGF) (TSX-V:LXG) (the “Company”), a biotechnology company that develops instrumentation for pathogen detection, announced today that it has entered into a collaborative agreement with Texas A&M Veterinary Medical Diagnostics Laboratory. Under this agreement, Texas A&M will provide canine urine samples to LexaGene for testing on the Company’s LX6 prototype for […]